Unusual Spindle Cell Squamous Carcinoma in a Renal Transplant Patient

Acta Dermato-Venereologica

Volumn 84, Issue 1, 2004, Pages 61-64

  Kurzen, Hjalmar ^a   Zeier, Martin ^a   Zelger, Bernhard ^b   Hartschuh, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cytokeratin; Immunohistochemistry; Immunosuppression; Skin; Spindle cell tumour

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CYTOKERATIN; DESMIN; PROTEIN S 100;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SCALP; SKIN NEOPLASMS;

EID: 0842264241     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310005852     Document Type: Article

References (29)

1. Hafner J, Künzi W, Weinreich T. Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999; 198: 29-32.
2. McGregor JM, Morris R, Smith CH, MacDonald DM. Skin cancer morbidity amongst renal allograft recipients - a 25-year retrospective follow-up study. Br J Dermatol 1995; 133: 40.
3. Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160: 251-258.
4. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
5. Smith KJ, Skelton HG, Morgan AM, Barrett TL, Lupton GP. Spindle cell neoplasms coexpressing cytokeratin and vimentin (metaplastic squamous cell carcinoma). J Cut Pathol 1992; 19: 286-293.
6. Zelger B, Soyer HP. Between Scylla and Charybdis. Mythology in dermatopathology. Dermatopathol: Pract & Concept 2000; 6: 348-355.
7. Kurzen H, Esposito L, Langbein L, Hartschuh W. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol 2001; 23: 501-509.
8. Helwig EG. Case 6-Atypical fibroxanthoma. In: 18th Annual Tumour seminar of the San Antonio Society of Pathologists. Tex Med 1963; 59: 664-667.
9. Lichtiger B, MacKay MB, Tessmer CF. Spindle-cell variant of squamous carcinoma: a light and electron microscopic study of 13 cases. Cancer 1970; 26: 1311-1320.
10. Hudson AW, Winkelmann RK. Atypical fibroxanthoma of the skin: a reappraisal of 19 cases in which the original diagnosis was spindle-cell squamous carcinoma. Cancer 1972; 29: 413-422.
11. Battifora H. Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by the tumour cells. Cancer 1976; 37: 2275-2282.
12. Barr RJ, Wuerker RB, Graham JH. Ultrastructure of atypical fibroxanthoma. Cancer 1977; 40: 736-743.
13. Evans HL, Smith JL. Spindle cell squamous carcinomas and sarcoma-like tumours of the skin: a comparative study of 38 cases. Cancer 1980; 45: 2687-2697.
14. Kuwano H, Hashimoto H, Enjoji M. Atypical fibroxanthoma distinguishable from spindle cell carcinoma in sarcoma-like skin lesions. Cancer 1985; 55: 172-180.
15. Silvis NG, Swanson PE, Manivel JC, Kaye VN, Wick MR. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas". Am J Dermatopathol 1988; 10: 9-19.
16. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin: a clinicopathological study of 140 cases. Cancer 1973; 31: 1541-1552.
17. Kemp JD, Stenn KS, Anons M, et al. Metastasizing atypical fibroxanthoma. Arch Dermatol 1978; 114: 1533-1535.
18. Weedon D, Kerr JRR. Atypical fibroxanthoma of the skin: an electron microscope study. Pathology 1975; 7: 173-177.
19. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell 1982; 31: 11-24.
20. Lane EB, Hogan BL, Kurkinen M, et al. Coexpression of vimentin and cytokeratin in partial endoderm cells of early embryo. Nature 1983; 303: 701-704.
21. Ikegawa S, Saida T, Takizawa Y, et al. Vimentin-positive squamous cell carcinoma arising in a burn scar. A highly malignant neoplasm composed of acantholytic round keratinocytes. Arch Dermatol 1989; 125: 1672-1676.
22. Demirkesen C, Hoede N, Moll R. Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. J Cutan Pathol 1995; 22: 518-535.
23. Bartek J, Vojtesek B, Staskova Z, Bartkova J, Kerekes Z, Rejthar A, et al. A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol 1991; 164: 215-224.
24. Bosch FX, Leube RE, Achtstätter T, Moll R, Franke WW. Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ. J Cell Biol 1988; 106: 1635-1648.
25. Schirren CG, Rütten A, Kaudewitz P, Diaz C, McClain S, Burgdorf WHC. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 1997; 19: 341-350.
26. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol 1999; 21: 332-336.
27. Morris JG, Joffe R. Perineural spread of cutaneous basal and squamous cell carcinomas. The clinical appearance of spread into the trigeminal and facial nerves. Arch Neurol 1983; 40: 424-429.
28. Schroeder TL, MacFarlane DF, Goldberg LH. Pain as an atypical presentation of squamous cell carcinoma. Dermatol Surg 1998; 24: 263-266.
29. Smit M, Balm AJ, Hilgers FJ, Tan IB. Pain as sign of recurrent disease in head and neck squamous cell carcinoma. Head Neck 2001; 23: 372-375.